Nimbus Therapeutics competitorsClear all

Codiak Biosciences's top competitors include Aligos Therapeutics and AstraZeneca.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Codiak Biosciences
Codiak Biosciences
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
Aligos Therapeutics
Aligos Therapeutics
Aligos Therapeutics is a company that develops curative therapies for hepatologic diseases and viral infections.
AstraZeneca
AstraZeneca
AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
Founding Date
Founding Date
2015
Founding Date
2018
Founding Date
1999
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
South San Francisco, US HQ
Leuven, BE
Locations
Cambridge, GB HQ
Alger, DZ
Buenos Aires, AR
Haedo, AR
Macquarie Park, AU
Macquarie Park, AU
North Ryde, AU
see more
Employees
Employees
101
Employees
8628% increase
Employees
76,1008% increase
Valuation ($)
Valuation ($)
151.4 m
Valuation ($)
130 m
Valuation ($)
166 b
Twitter followers
Twitter followers
208
Twitter followers
168
Twitter followers
297.8 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
25
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
2.5
Average likes per tweet (last 30 days)
2
Average likes per tweet (last 30 days)
27.1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
92%
Alexa Website Rank
Alexa Website Rank
309052
Alexa Website Rank
236419
Alexa Website Rank
102516
Employee Rating
Employee Rating
4.2
Employee Rating
N/A
Employee Rating
4.1

Financial

Revenue (est.)
Revenue (est.)
$2.9m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$24.4b (FY, 2019)
Net income
Net income
($91.7m) (FY, 2020)
Net income
($108.5m) (FY, 2020)
Net income
$1.2b (FY, 2019)

Operating

Pre-Clinical Phase Products
Pre-Clinical Phase Products
2 (Q2, 2020)
Pre-Clinical Phase Products
4 (Q2, 2020)
Pre-Clinical Phase Products
N/A

Funding

Total funding raised
Total funding raised
$ 168.5m
Total funding raised
$ 225m
Total funding raised
$ 1b
For sources of this data, please see the company profile

View company profiles

Aligos Therapeutics
HQ
South San Francisco, US
Employees
86↑ 28% increase

Aligos Therapeutics is a company that develops curative therapies for hepatologic diseases and viral infections.

View company
AstraZeneca
HQ
Cambridge, GB
Employees
76,100↑ 8% increase

AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.

View company